448 related articles for article (PubMed ID: 33110184)
1. Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses.
Hensel J; McAndrews KM; McGrail DJ; Dowlatshahi DP; LeBleu VS; Kalluri R
Sci Rep; 2020 Oct; 10(1):18377. PubMed ID: 33110184
[TBL] [Abstract][Full Text] [Related]
2. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Charoenlap S; Piromsopa K; Charoenlap C
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
[TBL] [Abstract][Full Text] [Related]
3. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
[TBL] [Abstract][Full Text] [Related]
4. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?
Sharma AR; Batra G; Kumar M; Mishra A; Singla R; Singh A; Singh RS; Medhi B
Allergol Immunopathol (Madr); 2020; 48(5):507-517. PubMed ID: 32653224
[TBL] [Abstract][Full Text] [Related]
5. Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration.
Ayoub BM; Ramadan E; Ashoush N; Tadros MM; Hendy MS; Elmazar MM; Mousa SA
Pharmazie; 2020 Aug; 75(8):375-380. PubMed ID: 32758336
[TBL] [Abstract][Full Text] [Related]
6. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
7. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M
Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142
[TBL] [Abstract][Full Text] [Related]
8. BCG epidemiology supports its protection against COVID-19? A word of caution.
Szigeti R; Kellermayer D; Trakimas G; Kellermayer R
PLoS One; 2020; 15(10):e0240203. PubMed ID: 33027297
[TBL] [Abstract][Full Text] [Related]
9. Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now).
Riccò M; Gualerzi G; Ranzieri S; Bragazzi NL
Acta Biomed; 2020 May; 91(2):207-213. PubMed ID: 32420947
[TBL] [Abstract][Full Text] [Related]
10. [Progress in possible effects of BCG vaccine on the prevention of SARS-CoV-2 infection: An update].
Huang W; Liu T; Feng G; Wang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1044-1048. PubMed ID: 33210600
[TBL] [Abstract][Full Text] [Related]
11. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
[TBL] [Abstract][Full Text] [Related]
12. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).
Escobar LE; Molina-Cruz A; Barillas-Mury C
Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17720-17726. PubMed ID: 32647056
[TBL] [Abstract][Full Text] [Related]
13. Factors determining COVID-19 pneumonia severity in a country with routine BCG vaccination.
Aksu K; Naziroğlu T; Özkan P
Clin Exp Immunol; 2020 Nov; 202(2):220-225. PubMed ID: 32813879
[TBL] [Abstract][Full Text] [Related]
14. Impact of Routine Infant BCG Vaccination on COVID-19.
Kinoshita M; Tanaka M
J Infect; 2020 Oct; 81(4):625-633. PubMed ID: 32795481
[TBL] [Abstract][Full Text] [Related]
15. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
Tomita Y; Sato R; Ikeda T; Sakagami T
Vaccine; 2020 Sep; 38(41):6352-6356. PubMed ID: 32863070
[TBL] [Abstract][Full Text] [Related]
16. Global impact of environmental temperature and BCG vaccination coverage on the transmissibility and fatality rate of COVID-19.
Kumar A; Misra S; Verma V; Vishwakarma RK; Kamal VK; Nath M; Prakash K; Upadhyay AD; Sahu JK
PLoS One; 2020; 15(10):e0240710. PubMed ID: 33091086
[TBL] [Abstract][Full Text] [Related]
17. Relation between BCG coverage rate and COVID-19 infection worldwide.
Macedo A; Febra C
Med Hypotheses; 2020 Sep; 142():109816. PubMed ID: 32408071
[No Abstract] [Full Text] [Related]
18. BCG as an adjunct or alternative vaccine to prevent COVID-19?
Weng CH; Chan PA
J Travel Med; 2020 Nov; 27(7):. PubMed ID: 33073845
[No Abstract] [Full Text] [Related]
19. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V
J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
Faust L; Schreiber Y; Bocking N
BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
